Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.14.14.47 extracted from

  • Holden, J.K.; Li, H.; Jing, Q.; Kang, S.; Richo, J.; Silverman, R.B.; Poulos, T.L.
    Structural and biological studies on bacterial nitric oxide synthase inhibitors (2013), Proc. Natl. Acad. Sci. USA, 110, 18127-18131.
    View publication on PubMedView publication on EuropePMC

Cloned(Commentary)

Cloned (Comment) Organism
-
Bacillus subtilis

Crystallization (Commentary)

Crystallization (Comment) Organism
incomplex with inhibitors 6-([(3R,5S)-5-][[[[(6-amino-4-methylpyridin-2-yl)methoxy]methyl]pyrrolidin-3-yl]oxy]methyl)-4-methylpyridin-2-amine and 6,6'-[[(2S,3S)-2-aminobutane-1,3-diyl]bis(oxymethanediyl)]bis(4-methylpyridin-2-amine) Bacillus subtilis

Inhibitors

Inhibitors Comment Organism Structure
6,6'-[[(2S,3S)-2-aminobutane-1,3-diyl]bis(oxymethanediyl)]bis(4-methylpyridin-2-amine) compound impedes the growth of Bacillus subtilis under oxidative stress an is able to displace the tetrahydrobiopterin cofactor in the Bacillus subtilis enzyme but not in the mouse enzyme Bacillus subtilis
6-([(3R,5S)-5-][[[[(6-amino-4-methylpyridin-2-yl)methoxy]methyl]pyrrolidin-3-yl]oxy]methyl)-4-methylpyridin-2-amine compound impedes the growth of Bacillus subtilis under oxidative stress Bacillus subtilis

Organism

Organism UniProt Comment Textmining
Bacillus subtilis O34453
-
-
Bacillus subtilis 168 O34453
-
-